About this trial
This is a prospective observational cohort study conducted in Qujiang District, Zhejiang Province, China, aiming to evaluate the effectiveness of a comprehensive management program for elderly patients with chronic cardiovascular diseases (CVDs). The program integrates pharmacological treatment, lifestyle modification, health education, and long-term follow-up, with enhanced monitoring using 7-day ECG recording. The study focuses on major chronic CVDs including hypertension, coronary artery disease, atrial fibrillation, and heart failure. Approximately 30,000 participants aged ≥60 years will be enrolled and followed for up to 10 years.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Community-dwelling elderly residents of Qujiang District with chronic cardiovascular diseases.
Trial design
Cohort
Prospective
Treatments tested in this trial
Comprehensive management program (pharmacologic treatment, lifestyle modification, health education, structured follow-up)
DeviceComprehensive management program (pharmacologic treatment, lifestyle modification, health education, structured follow-up) Enhanced monitoring with 7-day ECG
Treatment groups
Trial outcomes
Primary outcomes
Incidence of cardiovascular events
Incidence of cardiovascular events (myocardial infarction, stroke, hospitalization for heart failure, cardiovascular death) - assessed annually during follow-up
All-cause and cardiovascular mortality
All-cause and cardiovascular mortality - assessed at 10 years
Secondary outcomes
Hospitalization rates
Hospitalization rates (number and duration of hospitalizations for CVD-related causes)
Atrial fibrillation burden
Atrial fibrillation burden - time proportion of AF episodes, number of episodes, longest episode duration (measured during 7-day ECG monitoring in the blanking period and annually thereafter)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.